MIMS® Retrospective Chart Review
ConditionOpen Angle Glaucoma
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age40-85
SponsorSanoculis Ltd
About this trial
This is a post-market clinical follow-up, retrospective chart review of MIMS® surgical procedures conducted during time period between Sep 2023 and May 2025.
Eligibility criteria
Qualifiers
Eye treated with MIMS® Device as a standalone procedure
MIMS® surgery was performed between 27 Sep 2023 and 30 April 2024
Disqualifiers
None
Trial design
Treatments tested in this trial
- Minimally Invasive Micro Sclerostomy
Treatment groups
40 Participants
are divided into 1 treatment groupSponsors and collaborators
Source ClinicalTrials.gov